PSNL

Personalis (PSNL)

Personalis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PSNL

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/02/24	06:30	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PSNL	Personalis Inc
2023/02/24	06:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2023/02/24	06:01	Business Wire	Personalis Reports Fourth Quarter and Full Year 2022 Financial Results	NASDAQ:PSNL	Personalis Inc
2023/02/11	03:53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PSNL	Personalis Inc
2023/02/10	06:01	Business Wire	Personalis to Announce Fourth Quarter and Full Year 2022 Financial Results	NASDAQ:PSNL	Personalis Inc
2023/02/07	06:01	Business Wire	Personalis to Participate at Upcoming Investor Conferences	NASDAQ:PSNL	Personalis Inc
2023/02/03	22:45	Business Wire	Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials	NASDAQ:PSNL	Personalis Inc
2023/02/03	07:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2023/02/01	04:01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PSNL	Personalis Inc
2023/01/26	02:19	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PSNL	Personalis Inc
2023/01/19	06:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2023/01/05	06:01	Business Wire	Personalis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue	NASDAQ:PSNL	Personalis Inc
2022/12/23	07:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/12/20	06:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/12/17	06:05	Business Wire	Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PSNL	Personalis Inc
2022/12/15	06:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2022/12/15	06:02	Business Wire	Personalis Announces CEO Retirement and Transition	NASDAQ:PSNL	Personalis Inc
2022/12/07	06:55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/12/07	06:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/11/30	22:55	Business Wire	Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer	NASDAQ:PSNL	Personalis Inc
2022/11/22	06:01	Business Wire	Personalis to Present at the 34th Annual Piper Sandler Healthcare Conference	NASDAQ:PSNL	Personalis Inc
2022/11/19	06:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/11/08	06:05	Business Wire	Personalis Presents Data from New Platform Features at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting	NASDAQ:PSNL	Personalis Inc
2022/11/05	01:45	TipRanks	Morgan Stanley Keeps Their Hold Rating on Personalis (PSNL)	NASDAQ:PSNL	Personalis Inc
2022/11/04	14:45	TipRanks	BTIG Sticks to Their Buy Rating for Personalis (PSNL)	NASDAQ:PSNL	Personalis Inc
2022/11/03	19:30	TipRanks	Analysts Offer Insights on Healthcare Companies: Matinas BioPharma (MTNB), Seres Therapeutics (MCRB) and Personalis (PSNL)	NASDAQ:PSNL	Personalis Inc
2022/11/03	18:15	TipRanks	Needham Remains a Hold on Personalis (PSNL)	NASDAQ:PSNL	Personalis Inc
2022/11/03	05:31	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PSNL	Personalis Inc
2022/11/03	05:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2022/11/03	05:01	Business Wire	Personalis Reports Third Quarter 2022 Financial Results	NASDAQ:PSNL	Personalis Inc